Second hot round of impotence drug markets.

Published: 2004-09-10 07:00:00

Updated: 2004-09-10 07:00:00

Celebrating the 5th year and 1st year anniversaries for Viagra and the followers like Levitra and Cialis, they are now getting into the second round of the market competition that seemed to be far sharp struggles than the first round because they thought once the fight failed the aftermath likely...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK